首页 | 官方网站   微博 | 高级检索  
     

衰竭期骨髓转移癌临床表现及其治疗对策
引用本文:邱立华, 王华庆, 刘贤明, 张会来, 钱正子, 李 维, 侯 芸, 周世勇, 郝希山. 衰竭期骨髓转移癌临床表现及其治疗对策[J]. 中国肿瘤临床, 2010, 37(9): 523-526. DOI: 10.3969/j.issn.1000-8179.2010.09.011
作者姓名:邱立华  王华庆  刘贤明  张会来  钱正子  李维  侯芸  周世勇  郝希山
作者单位:作者单位:天津市肿瘤防治重点实验室,天津医科大学附属肿瘤医院淋巴瘤内科(天津市300060)
摘    要:目的:探讨衰竭期骨髓转移癌(MCBM)的发病率、病史、临床表现、诊断要点和治疗方法。方法:对疑似病例行骨髓穿刺和(或)活检、PET-CT 检查,病理学确诊者中9 例行抢救性化疗联合最佳支持治疗(BSC),另6 例仅给予BSC ,收集患者症状、体征、病史、体质状态评分(KPS 评分)、血常规、骨髓特点、合并症、缓解率、生存期等数据。结果:2 876 例患者中发现该病15例,临床表现为进行性加重的乏力,病史多不足3 个月,部分患者有实体瘤病史而另一部分患者疑似血液系统疾患而就诊,骨髓均增生低下有时可发现有分类不明的细胞或较为典型的转移瘤细胞,并有贫血,KPS 评分不足50分,14例伴血小板减少症,3 例合并弥散性血管内凝血(DIC)。 其中9 例接受了抢救性化疗及BSC ,临床受益率88.9%(8/9),生存期20天至5 年7 个月;而仅接受BSC 者生存期仅为20天至3 个月。结论:衰竭期骨髓转移癌临床罕见,起病隐匿,病史多不足3 个月,临床表现为不明原因并进行性加重的贫血和血小板减少症,诊断亦较为困难,骨髓检查常显示骨髓增生低下有时可发现有分类不明的细胞或较为典型的转移瘤细胞,该病的治疗国内外尚无成功的经验和方法,减量的抢救性化疗联合BSC 可能有效,生存期明显延长,打破了该期患者不宜化疗的传统观念。

关 键 词:骨髓转移癌  衰竭期  化疗  抢救性
收稿时间:2009-06-24
修稿时间:2009-09-07

Clinical Characteristics of Patients with Metastatic Carcinoma in Bone Marrow in Exhaustion Phase and the Value of Emergency Chemotherapy Combined with Best Supportive Care as a Treatment Strategy
QIU Lihua, WANG Huaqing, LIU Xianming, ZHANG Huilai, QIAN Zhengzi, LI Wei, HOU Yun, ZHOU Shiyong, HAO Xishan. Clinical Characteristics of Patients with Metastatic Carcinoma in Bone Marrow in Exhaustion Phase and the Value of Emergency Chemotherapy Combined with Best Supportive Care as a Treatment Strategy[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 37(9): 523-526. DOI: 10.3969/j.issn.1000-8179.2010.09.011
Authors:QIU Lihua  WANG Huaqing  LIU Xianming  ZHANG Huilai  QIAN Zhengzi  LI Wei  HOU Yun  ZHOU Shiyong  HAO Xishan
Affiliation:Department of Medical Oncology, Cancer Institute and Hospital of Tianjin Medical University, Tianjin 300060, China
Abstract:Objective:To study the incidence of metastatic carcinoma in bone marrow (MCBM) in the exhaustion phase and its clinical characteristics, and to explore the value of emergency chemotherapy combined with best supportive care (BSC).Methods:Patients with suspected MCBM in the exhaustion phase were examined by bone marrow puncture and/or biopsy together with PET-CT scans. Nine patients with MCBM received emergency chemotherapy and BSC and the other 6 patients only received BSC. Clinical outcomes, significant history, bone marrow, outcome of routine blood examination, Karnofsky Score (KPS score), complications, remission rate and patient survival were analyzed after treatment. Results: Among2,876 patients, 15cases were found with MCBM in the exhaustion phase. These 15cases had anemia and a histo-ry of less than 3 months. They had bone marrow hypoplasia and KPS scores less than50. Among them, 14cases had thrombocytopenia and 3 cases had disseminated intravascular coagulation (DIC). For the 9 patients treated with emergen-cy chemotherapy and BSC, the clinical benefit rate was 88.9% (8/9) and the survival was 20days to5 years and 7 months. The other 6 patients treated with only BSC had a short survival time ( 20days to 3 months). Conclusion:MCBM in the ex-haustion phase is rare and the onset is occult. Clinical manifestations are anemia, thrombocytopenia and bone marrow hy-poplasia with or without solid tumor history. The diagnosis is difficult. Emergency chemotherapy with reduced dosage in combination with BSC may be of benefit for patients with MCBM in the exhaustion phase and can increase patient survival. 
Keywords:Metastatic carcinoma in bone marrow  Exhausted phase  Chemotherapy  Emergency
本文献已被 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号